StonvexLoading…
StonvexStonvexStonvexCore line items from HRTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $154.90M | $144.28M | $127.04M | $107.67M |
Operating Income | $-2.54M | $-11.53M | $-110.61M | $-174.66M |
Net Income | $-20.20M | $-13.58M | $-110.56M | $-182.02M |
EPS (Diluted) | $-0.12 | $-0.09 | $-0.80 | $-1.67 |
Total Assets | $255.88M | $233.15M | $222.51M | $250.95M |
Total Liabilities | $241.54M | $266.80M | $256.48M | $237.38M |
Cash & Equivalents | $28.65M | $25.80M | $28.68M | $15.36M |
Free Cash Flow OCF − CapEx | $-27.91M | $-24.23M | $-60.33M | $-148.74M |
Shares Outstanding | 188.31M | 152.13M | 150.29M | 119.15M |